Print Page Print Page
E-mail Page E-mail Page
RSS Feeds RSS Feeds
Share Page Share Page
E-mail Alerts E-mail Alerts
Financial Tear Sheet Financial Tear Sheet

Investor Relations

Otonomy is a biopharmaceutical company dedicated to the development of innovative therapeutics for diseases and disorders of the ear. The company pioneered the application of drug delivery technology to the ear in order to develop products that achieve sustained drug exposure from a single local administration. This approach is covered by a broad patent estate and is being utilized to develop a pipeline of products addressing important unmet medical needs including Ménière’s disease, hearing loss, and tinnitus.
Stock Quote
OTIC (Common Stock)
ExchangeNASDAQ GS (US Dollar)
Change (%) Stock is Up 0.05 (1.14%)
Data as of 03/22/18 3:30 p.m. ET
Minimum 20 minute delay
Refresh quote
Stock Chart
Stock chart for: OTIC.OQ.  Currently trading at $4.45 with a 52 week high of $21.15 and a 52 week low of $2.80.
Recent NewsMore >>
03/08/18Otonomy Reports Fourth Quarter and Full Year 2017 Financial Results and Provides Corporate UpdatePrinter Friendly Version
03/06/18Otonomy to Present at Cowen and Company Health Care ConferencePrinter Friendly Version
Investor Presentations
Download Documentation Corporate Presentation – March 8 2018
Download Documentation AVERTS-2 Topline Results
Download Documentation AVERTS-1 Topline Results
Download Documentation Meniere’s Disease KOL Breakfast
Upcoming EventsMore >>
There are currently no events scheduled.
Receive E-mail AlertsE-mail Alert Icon
Sign up to receive e-mail alerts whenever Otonomy Inc posts new information to the site. Just enter your e-mail address and click Submit.
Data provided by Nasdaq. Minimum 15 minutes delayed. View Attributions and Sources